|
FY2025
12 months to Dec 31, 2025
|
FY2024
12 months to Dec 31, 2024
|
FY2023
12 months to Dec 31, 2023
|
FY2022
12 months to Dec 31, 2022
|
FY2021
12 months to Dec 31, 2021
|
|
|---|---|---|---|---|---|
| Net sales | |||||
| Cost of sales | |||||
| Gross profit | |||||
| Operating expenses | |||||
| Distribution | |||||
| Research and development | |||||
| Selling | |||||
| Administration | |||||
| Impairment charges | |||||
| Restructuring | |||||
| Other operating (income) expense, net | |||||
| Other operating (income) expense, net | |||||
| Total operating expenses | |||||
| Operating income (loss) | |||||
| Interest expense, net | |||||
| Other (income) expense, net | |||||
| Loss on extinguishment of debt | |||||
| Income (loss) from continuing operations before income taxes | |||||
| Income tax expense | |||||
| Loss from continuing operations | |||||
| Loss from discontinued operations, net of tax | |||||
| Net income (loss) | |||||
| Earnings (loss) per share | |||||
| Basic | |||||
| Continuing operations (in dollars per share) | |||||
| Discontinued operations (in dollars per share) | |||||
| Basic earnings (loss) per share (in dollars per share) | |||||
| Diluted | |||||
| Continuing operations (in dollars per share) | |||||
| Discontinued operations (in dollars per share) | |||||
| Diluted earnings (loss) per share (in dollars per share) | |||||
| Weighted-average shares outstanding | |||||
| Basic (in shares) | |||||
| Diluted (in shares) | |||||
Loading...